• Program & Facility Leadership: Oversight of NIH-Vaccine Research center’s bioanalytical mass spectrometry facility supporting GMP vaccine manufacturing – strategic planning, capital budgeting, resource allocation, purchase coordination.
• Analytical Strategy & CMC Integration: End-to-end analytical leadership for monoclonal antibodies, subunit vaccines, and mRNA therapeutics.
• Cross-Functional Collaboration: Partnering with cell line development, purification, formulation, automation, and regulatory teams of vaccine production program.
• Innovation & Automation: Implemented high-throughput Multi-attribute monitoring method workflows and automated analytical pipelines for biotherapeutic manufacturing support.
• Chemistry & Biochemistry: Extensive expertise in analytical and synthetic chemistry, chemical probe design, drug discovery, bioconjugation, and carbohydrate chemistry.
• Biological/Pharmacological Translation: Deep specialization in mass spectrometry-driven workflows.
Bioanalytical scientist
Asif Shajahan, PhD
Scientific lead with extensive experience in mass spectrometry-driven analytical development of biotherapeutics.
Vaccine Research Center, National Institutes of Health
LinkedIn profileAreas of expertise
- Biomarker strategy and diagnostics
- Biotech Startups
- Research and Development